Abbott Laboratories (ABT) Acquisitions: History & Chart

Abbott Laboratories(ABT)

Medical - Devices · Abbott Park, IL

$105.25-0.27 (-0.26%)

Delayed quote: Sep 9, 2026, 4:00 PM EDT

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL

115,000 employees

www.abbott.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Robert Ford

View full financials

Acquisitions

The latest quarterly acquisitions is −$164.00 Million with a QoQ Growth of +99.17%. Acquisitions represent cash spent to acquire other businesses and show externally purchased growth activity.

Goodwill|Revenue|CapEx|Free Cash Flow|Cash Flow

Acquisitions

ABT Acquisitions

$-164.00M

Reported quarterly acquisitions; no daily interpolation. Q2 FY2026 (2026-06-30): $-164.00M.

-148.48% over 10Y

Current Acquisitions

−$164.00M

−$164.00 Million

QoQ Growth

+99.17%

vs. −$19.80B prior quarter

Historical Data

Quarters of data available

Quarterly Acquisitions History

Period	Acquisitions	QoQ Growth	YoY Growth
Q2 FY2026Period end 2026-06-30	−$164.00M	+99.17%	N/A
Q1 FY2026Period end 2026-03-31	−$19.80B	-39496.00%	N/A
Q4 FY2025Period end 2025-12-31	−$50.00M	+9.09%	N/A
Q3 FY2025Period end 2025-09-30	−$55.00M	N/A	N/A
Q2 FY2025Period end 2025-06-30	$0	N/A	N/A
Q1 FY2025Period end 2025-03-31	$0	N/A	N/A
Q4 FY2024Period end 2024-12-31	$0	N/A	N/A
Q3 FY2024Period end 2024-09-30	$0	N/A	N/A
Q2 FY2024Period end 2024-06-30	$1.00M	N/A	N/A
Q1 FY2024Period end 2024-03-31	$0	N/A	N/A
Q4 FY2023Period end 2023-12-31	$0	N/A	N/A
Q3 FY2023Period end 2023-09-30	−$51.00M	+93.51%	N/A
Q2 FY2023Period end 2023-06-30	−$786.00M	N/A	N/A
Q1 FY2023Period end 2023-03-31	$0	N/A	N/A
Q4 FY2022Period end 2022-12-31	$0	N/A	N/A
Q3 FY2022Period end 2022-09-30	$0	-100.00%	N/A
Q2 FY2022Period end 2022-06-30	$48.00M	N/A	0.00%
Q1 FY2022Period end 2022-03-31	$0	N/A	N/A
Q4 FY2021Period end 2021-12-31	−$134.00M	-55.81%	-131.03%
Q3 FY2021Period end 2021-09-30	−$86.00M	N/A	N/A
Q2 FY2021Period end 2021-06-30	$48.00M	N/A	N/A
Q1 FY2021Period end 2021-03-31	−$15.00M	+74.14%	N/A
Q4 FY2020Period end 2020-12-31	−$58.00M	N/A	N/A
Q3 FY2020Period end 2020-09-30	$0	N/A	N/A
Q2 FY2020Period end 2020-06-30	$16.00M	N/A	N/A
Q1 FY2020Period end 2020-03-31	$0	N/A	N/A
Q4 FY2019Period end 2019-12-31	$1.00M	N/A	N/A
Q3 FY2019Period end 2019-09-30	−$11.00M	+67.65%	N/A
Q2 FY2019Period end 2019-06-30	−$34.00M	+56.41%	N/A
Q1 FY2019Period end 2019-03-31	−$78.00M	-62.50%	-212.00%
Q4 FY2018Period end 2018-12-31	−$48.00M	N/A	+98.30%
Q3 FY2018Period end 2018-09-30	$0	-100.00%	-100.00%
Q2 FY2018Period end 2018-06-30	$48.00M	N/A	-79.83%
Q1 FY2018Period end 2018-03-31	−$25.00M	+99.12%	+99.57%
Q4 FY2017Period end 2017-12-31	−$2.83B	N/A	N/A
Q3 FY2017Period end 2017-09-30	$24.00M	-89.92%	N/A
Q2 FY2017Period end 2017-06-30	$238.00M	N/A	N/A
Q1 FY2017Period end 2017-03-31	−$5.87B	N/A	N/A
Q4 FY2016Period end 2016-12-31	−$7.00M	+89.39%	+99.72%
Q3 FY2016Period end 2016-09-30	−$66.00M	N/A	+71.43%
Q2 FY2016Period end 2016-06-30	−$7.00M	N/A	N/A
Q1 FY2016Period end 2016-03-31	$25.00M	N/A	-89.13%
Q4 FY2015Period end 2015-12-31	−$2.52B	-990.91%	-409.09%
Q3 FY2015Period end 2015-09-30	−$231.00M	N/A	+91.81%
Q2 FY2015Period end 2015-06-30	$2.29B	+893.91%	N/A
Q1 FY2015Period end 2015-03-31	$230.00M	N/A	N/A
Q4 FY2014Period end 2014-12-31	−$495.00M	+82.46%	N/A
Q3 FY2014Period end 2014-09-30	−$2.82B	N/A	-398.35%
Q2 FY2014Period end 2014-06-30	$0	N/A	N/A
Q1 FY2014Period end 2014-03-31	$0	N/A	N/A
Q4 FY2013Period end 2013-12-31	−$13.73M	+97.58%	+45.08%
Q3 FY2013Period end 2013-09-30	−$566.27M	N/A	-34.31%
Q2 FY2013Period end 2013-06-30	$0	N/A	N/A
Q1 FY2013Period end 2013-03-31	$0	N/A	N/A
Q4 FY2012Period end 2012-12-31	−$25.00M	+94.07%	+100.00%
Q3 FY2012Period end 2012-09-30	−$421.62M	-283.29%	+13.07%
Q2 FY2012Period end 2012-06-30	−$110.00M	+83.60%	+41.33%
Q1 FY2012Period end 2012-03-31	−$670.85M	+99.90%	N/A
Q4 FY2011Period end 2011-12-31	−$671.83B	-138421.13%	-214404.31%
Q3 FY2011Period end 2011-09-30	−$485.00M	-158.67%	+77.95%
Q2 FY2011Period end 2011-06-30	−$187.50M	N/A	+62.83%
Q1 FY2011Period end 2011-03-31	$0	N/A	N/A
Q4 FY2010Period end 2010-12-31	−$313.20M	+85.76%	+63.23%
Q3 FY2010Period end 2010-09-30	−$2.20B	-336.17%	N/A
Q2 FY2010Period end 2010-06-30	−$504.39M	+92.14%	-2810.20%
Q1 FY2010Period end 2010-03-31	−$6.42B	-653.25%	-329.99%
Q4 FY2009Period end 2009-12-31	−$851.73M	N/A	-240.69%
Q3 FY2009Period end 2009-09-30	−$9.51M	+45.12%	N/A
Q2 FY2009Period end 2009-06-30	−$17.33M	+98.84%	N/A
Q1 FY2009Period end 2009-03-31	−$1.49B	-496.82%	N/A
Q4 FY2008Period end 2008-12-31	−$250.00M	N/A	N/A
Q3 FY2008Period end 2008-09-30	$0	N/A	N/A
Q2 FY2008Period end 2008-06-30	$0	N/A	N/A
Q1 FY2008Period end 2008-03-31	$0	-100.00%	N/A
Q4 FY2007Period end 2007-12-31	$906.47M	N/A	N/A
Q3 FY2007Period end 2007-09-30	$0	N/A	N/A
Q2 FY2007Period end 2007-06-30	$0	N/A	N/A
Q1 FY2007Period end 2007-03-31	$0	N/A	N/A
Q4 FY2006Period end 2006-12-31	−$3.60B	N/A	-1240.58%
Q3 FY2006Period end 2006-09-30	−$1.60M	N/A	N/A
Q2 FY2006Period end 2006-06-30	$0	N/A	N/A
Q1 FY2006Period end 2006-03-31	$0	N/A	N/A
Q4 FY2005Period end 2005-12-31	−$268.58M	N/A	+25.90%
Q3 FY2005Period end 2005-09-30	$0	N/A	N/A
Q2 FY2005Period end 2005-06-30	$0	N/A	N/A
Q1 FY2005Period end 2005-03-31	$0	N/A	N/A
Q4 FY2004Period end 2004-12-31	−$362.47M	N/A	-965.21%
Q3 FY2004Period end 2004-09-30	$0	N/A	N/A
Q2 FY2004Period end 2004-06-30	−$1.59B	-328.17%	N/A
Q1 FY2004Period end 2004-03-31	−$372.11M	-993.53%	N/A
Q4 FY2003Period end 2003-12-31	−$34.03M	+84.66%	N/A
Q3 FY2003Period end 2003-09-30	−$221.82M	N/A	N/A
Q2 FY2003Period end 2003-06-30	$0	N/A	N/A
Q1 FY2003Period end 2003-03-31	$0	-100.00%	N/A
Q4 FY2002Period end 2002-12-31	$66.29M	N/A	N/A
Q3 FY2002Period end 2002-09-30	$0	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.

Data as of June 30, 2026

Acquisitions

ABT Acquisitions

Current Acquisitions

QoQ Growth

Historical Data

Quarterly Acquisitions History

Related Metrics